Thermo Fisher Scientific Inc. (TMO) Shares Sold by Bank of Hawaii

Bank of Hawaii lessened its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 19.4% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 14,817 shares of the medical research company’s stock after selling 3,577 shares during the period. Bank of Hawaii’s holdings in Thermo Fisher Scientific were worth $2,813,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Americafirst Capital Management LLC purchased a new position in shares of Thermo Fisher Scientific in the third quarter worth about $876,000. Rockland Trust Co. increased its stake in shares of Thermo Fisher Scientific by 7.3% in the fourth quarter. Rockland Trust Co. now owns 62,332 shares of the medical research company’s stock worth $11,836,000 after purchasing an additional 4,221 shares in the last quarter. San Francisco Sentry Investment Group CA purchased a new position in shares of Thermo Fisher Scientific in the second quarter worth about $1,451,000. Huntington National Bank increased its stake in shares of Thermo Fisher Scientific by 2.4% in the third quarter. Huntington National Bank now owns 195,348 shares of the medical research company’s stock worth $36,959,000 after purchasing an additional 4,655 shares in the last quarter. Finally, Toronto Dominion Bank increased its stake in shares of Thermo Fisher Scientific by 25.4% in the second quarter. Toronto Dominion Bank now owns 134,277 shares of the medical research company’s stock worth $23,424,000 after purchasing an additional 27,178 shares in the last quarter. Institutional investors and hedge funds own 86.54% of the company’s stock.

In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 50,000 shares of Thermo Fisher Scientific stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $191.74, for a total transaction of $9,587,000.00. Following the completion of the sale, the chief executive officer now directly owns 302,577 shares in the company, valued at $58,016,113.98. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Gregory J. Herrema sold 33,327 shares of Thermo Fisher Scientific stock in a transaction that occurred on Friday, February 2nd. The shares were sold at an average price of $219.70, for a total transaction of $7,321,941.90. Following the sale, the senior vice president now owns 60,471 shares of the company’s stock, valued at $13,285,478.70. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 95,327 shares of company stock valued at $19,470,342. 0.49% of the stock is currently owned by company insiders.

Several research firms have recently weighed in on TMO. Morgan Stanley lifted their target price on shares of Thermo Fisher Scientific from $223.00 to $227.00 and gave the stock an “overweight” rating in a research note on Thursday, February 1st. Leerink Swann reiterated an “outperform” rating and issued a $239.00 target price (up previously from $200.00) on shares of Thermo Fisher Scientific in a research note on Thursday, February 1st. They noted that the move was a valuation call. ValuEngine upgraded shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating in a research note on Friday, February 2nd. Barclays lifted their target price on shares of Thermo Fisher Scientific from $225.00 to $245.00 and gave the stock an “overweight” rating in a research note on Thursday, February 1st. Finally, BTIG Research began coverage on shares of Thermo Fisher Scientific in a research note on Friday, January 5th. They issued a “buy” rating and a $230.00 target price for the company. Two investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $220.50.

Thermo Fisher Scientific Inc. (NYSE:TMO) opened at $209.13 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 1.35 and a quick ratio of 0.92. Thermo Fisher Scientific Inc. has a 1 year low of $151.74 and a 1 year high of $226.44. The company has a market cap of $83,860.00, a P/E ratio of 34.28, a PEG ratio of 1.52 and a beta of 1.11.

Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings data on Wednesday, January 31st. The medical research company reported $2.79 EPS for the quarter, beating analysts’ consensus estimates of $2.66 by $0.13. Thermo Fisher Scientific had a net margin of 10.64% and a return on equity of 16.01%. The company had revenue of $6.05 billion during the quarter, compared to analyst estimates of $5.72 billion. During the same period last year, the business earned $2.41 earnings per share. Thermo Fisher Scientific’s revenue was up 22.1% compared to the same quarter last year. analysts predict that Thermo Fisher Scientific Inc. will post 10.81 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Monday, April 16th. Shareholders of record on Thursday, March 15th will be given a dividend of $0.17 per share. The ex-dividend date is Wednesday, March 14th. This is a positive change from Thermo Fisher Scientific’s previous quarterly dividend of $0.15. This represents a $0.68 annualized dividend and a yield of 0.33%. Thermo Fisher Scientific’s payout ratio is presently 9.84%.

COPYRIGHT VIOLATION NOTICE: This article was published by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this article on another website, it was stolen and reposted in violation of international trademark and copyright laws. The correct version of this article can be accessed at https://stocknewstimes.com/2018/02/23/thermo-fisher-scientific-inc-tmo-shares-sold-by-bank-of-hawaii.html.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply